Login
$XWEL
$0.75 +$0.07 (10.48%) Close

$XWEL SEC Filings

Filed On Filing
21 Oct 2026 DEFA14A
20 Oct 2026 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

08 Oct 2026 Proxy statement: special meeting on October 28, 2026
08 Oct 2026 8-K: Entry into a Material Definitive Agreement

THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of __________________, 2026, by and between __________________ (“Seller”) and XpresTest, Inc., a Delaware corporation (the “Company” or “Purchaser”).

08 Sep 2026 SCHEDULE 13D/A
04 Sep 2026 Form 4: Reid Gerard, Director

Received 150,000 shares as a grant or award

04 Sep 2026 Form 3: Reid Gerard, Director

No securities owned

03 Sep 2026 Form 4: Wizenberg Gaelle Sandra, Director

Received 50,000 shares as a grant or award

02 Sep 2026 Form 4: Weinstein Robert, Director

Received 50,000 shares as a grant or award

02 Sep 2026 Form 4: Bernstein Bruce, Director

Received 500,000 shares as a grant or award

02 Sep 2026 Form 4: Lebowitz Michael, Director

Received 50,000 shares as a grant or award

14 Aug 2026 10-Q
13 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 SCHEDULE 13G/A
05 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
04 Aug 2026 SCHEDULE 13D
27 Jul 2026 PREM14A
09 Jul 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
11 Jun 2026 SCHEDULE 13G
20 May 2026 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support